Position in DYN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$25,382,000
+$932,000 QoQ
Shares Held
1,400,000
+12.0% QoQ
Ownership
0.980%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Logos Global Management LP holds $1,835,814,678 across 59 Biotechnology names. DYN ranks #25 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,000,000 | $194,500,000 | |
| 2 | ERAS |
Erasca, Inc.
|
11,150,000 | $180,407,000 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
3,450,000 | $114,954,000 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
285,000 | $91,824,150 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
2,125,000 | $84,405,000 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
1,500,000 | $79,080,000 | |
| 7 | ABVX |
Abivax S.A.
|
675,000 | $75,161,250 | |
| 8 | TNGX |
Tango Therapeutics, Inc.
|
3,000,000 | $62,760,000 |
All Filings in DYN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $25,382,000 | 1,400,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,450,000 | 1,250,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $30,360,000 | 2,400,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $18,088,000 | 1,900,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,230,000 | 500,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,602,000 | 450,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,747,200 | 160,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,351,850 | 265,000 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $49,114,700 | 1,730,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $25,004,000 | 1,880,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,532,800 | 2,180,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $20,025,000 | 1,780,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $19,584,000 | 1,700,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $24,918,500 | 2,150,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $29,048,976 | 2,287,321 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,923,000 | 2,900,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $26,359,538 | 2,734,392 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $38,456,920 | 3,234,392 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $58,778,926 | 3,619,392 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $43,224,407 | 2,054,392 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $49,764,207 | 3,204,392 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $33,692,232 | 1,604,392 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $32,392,674 | 1,604,392 | Shares | Sole | 2020-11-17 | |
| No filing history on record for this holder in this stock. | ||||||